AGC Biologics at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
AGC Biologics brings 3 presentations to ESGCT 2026 in Hamburg. Its contributions centre on manufacturing viral vectors and engineered cells, comparing integrated and modular platforms for making lentivirally modified T cells. Other work covers cell line and process changes for AAV supply and carrying lentiviral know-how into therapies given in the body.
| Organization | ESGCT 2026 Attendance |
|---|---|
AGC Biologics Bothell, Washington | ◆Gold Sponsor |
Global CDMO providing process development, cGMP manufacturing and testing for proteins, plasmid DNA, mRNA, viral vectors and engineered cells. | Poster Thu Oct 29 2:00pm–4:00pm A comparative analysis of integrated and modular platforms for manufacturing T cells genetically modified with lentiviral vectors Poster Thu Oct 29 2:00pm–4:00pm BravoAAVTM: Advancing AAV Vector Manufacturing Through Process and Cell Line Innovation Poster Thu Oct 29 2:00pm–4:00pm From ex vivo to in vivo: leveraging established lentiviral vector manufacturing expertise to meet the next frontier of gene therapy |
Instantly find 20 buyers from AGC Biologics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction